Zoloft Sales Depressed By Adverse Publicity Surrounding Antidepressant Safety
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer reports a 6% decline in Zoloft sales for third quarter, which the company attributes to publicity surrounding pediatric suicidality associated with antidepressants. FDA’s proposed relabeling likely means the end of TV ads for the brand.